HNSA · Hansa Biopharma AB · Investor Relations
Market Cap
3.37B SEK
Shares
99.73M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-24 | Hansa Biopharma Corporate Presentation July 2026 | Presentation |
| 2026-07-22 | Interim Report January-June 2026 Conference Call | Earnings call |
| 2026-07-15 | Hansa Biopharma Capital Markets Day 2026 | Presentation |
| 2026-07-02 | Hansa Biopharma Corporate Presentation June 2026 | Presentation |
| 2026-05-27 | 20-HMedIdeS-19 Topline Results Post Authorization Efficacy Study (PAES) | Event |
| 2026-05-19 | Hansa Biopharma €115 Million Out Licensing of Idefirix in Europe and MENA to SERB | Event |
| 2026-04-14 | Hansa Biopharma Corporate Presentation April 2026 | Presentation |
| 2026-03-13 | Leerink Global Healthcare Conference - Hansa Biopharma Fireside Chat | Conference |
| 2026-03-13 | Hansa Biopharma Corporate Presentation March 2026 | Presentation |
| 2026-02-11 | Q4 Earnings Report 2025 Presentation | Presentation |
| 2026-01-12 | Hansa Biopharma Corporate Presentation January 2026 | Presentation |